Two NICE teams (NICE International and the Science Policy and Research Programme) will act as key en...
Read moreThe study looks at the direct, indirect and mortality-related costs of 24 rare diseases across five ...
Read moreAmgen’s Lumykras (sotorasib) has become the first active new technology to come through the Innova...
Read moreParacetamol and ibuprofen combinations are set to become available in pharmacies without a prescript...
Read moreAccording to the pharmaceutical industry association, Farmaindustria, 40% of orphan drugs approved i...
Read moreThe National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s Zej...
Read moreAccording to the National Agency for Drug Safety, there are currently four treatments available thro...
Read moreThe Ministry of Health hhas published a report on the “evolution of funding and fixing of the pric...
Read more14 new orphan drugs were made available in the national health service (Sistema Nacional de Salud, S...
Read moreOn 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...
Read more